The results of the present study suggest that dicholine salt of succinic acid, the novel neuronal insulin sensitizer, ameliorates cognitive deficits and neuronal dysfunctions in animal models relevant to age-related cognitive impairments, vascular dementia, and Alzheimer's disease. The gene discussed is INS; the disease is Cognitive impairment.